China NIPT Market to Grow at an Astounding CAGR of 30% During 2013-2018
As per the new research report by RNCOS, “Emerging NIPT Market in Asia Pacific”, the market for non-invasive prenatal testing in China is expanding at a rapid rate. This growth can be attributed to several factors, foremost of all being its high acceptance amongst high-risk pregnant women. Currently, BGI Health, a subsidiary of BGI China and Berry Genomics are the only two players in the highly lucrative market of China NIPT. Both the firms started offering their NIPT services in...
View full press release